The charts on this page feature a breakdown of the total annual pay for the top executives at SPECTRUM PHARMACEUTICALS INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. SPECTRUM PHARMACEUTICALS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. SPECTRUM PHARMACEUTICALS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Kurt A. Gustafson
Executive Vice President and Chief Financial Officer
Total Cash $810,000 Equity $1,137,566 Other $143,386 Total Compensation $2,090,952
Joseph W. Turgeon
President and Chief Executive Officer
Total Cash $1,275,000 Equity $2,293,442 Other $144,776 Total Compensation $3,713,218
Thomas J. Riga
Executive Vice President, Chief Operating Officer and Chief Commercial Officer
Total Cash $880,000 Equity $1,490,427 Other $152,372 Total Compensation $2,522,799
Keith M. McGahan
Executive Vice President, Chief Legal Officer and Corporate Secretary
Total Cash $750,000 Equity $1,099,031 Other $92,186 Total Compensation $1,941,217
Francois J. Lebel M.D.
Executive Vice President and Chief Medical Officer
Total Cash $810,000 Equity $1,297,755 Other $116,763 Total Compensation $2,224,518
For its 2020 fiscal year, SPECTRUM PHARMACEUTICALS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Joseph W. Turgeon CEO Pay $3,713,218 Median Employee Pay $146,715 CEO Pay Ratio 25:1
For its 2019 fiscal year, SPECTRUM PHARMACEUTICALS INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Anthony E. Maida Total Cash $47,500
Bernice R. Welles Total Cash $267,115
Dolatrai M. Vyas Total Cash $257,115
Elizabeth A. Czerepak Total Cash $224,615
Gilles R. Gagnon Total Cash $32,500
Jeffrey L. Vacirca Total Cash $262,115
Raymond W. Cohen Total Cash $277,115
Stuart M. Krassner Total Cash $57,500
William L. Ashton Total Cash $272,115

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.